MDT Rating

MDT Intrinsic Value

Key Highlights:
As of Mar 03, 2025 MDT Relative Value is $140.1, which is undervalued by 48.6%, compared to current share price of $94.3.
As of Mar 03, 2025 MDT DCF Value is $88.3, which is overvalued by 6.4%, compared to current share price of $94.3.
Methodology
Price per share, $
Current share price
94.3

MDT Share Price History

1W 4.6%
1M 4.2%
6M 7.8%
YTD 17.7%
1Y 14.7%
3Y (3.5%)
5Y 8.3%
10Y 54.8%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!

MDT Stock Metrics

Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$120.9B
Shares Outstanding
1,282M
Employees
N/A
Valuation (LTM)
Return on Capital
Earnings
May 22, 2025
BEAT by 0.8%
10 Beat & null Miss

MDT Stock Financials

MDT Income Statement Metrics

Annual
Quarterly
LTM

Revenue

$32.4B +3.6% YoY

Operating Income

$5.1B -6.2% YoY

Net Income

$3.7B -2.2% YoY

MDT Cash Flow Statement Metrics

Annual
Quarterly
LTM

Operating Cash Flow (OCF)

$6,787.0M +12.4% YoY

Capital Expenditure (CAPEX)

($1,587.0M) +8.8% YoY

Free Cash Flow (FCF)

$5,200.0M +13.5% YoY

MDT Income Statement Overview

Annual
Quarterly
LTM
Apr'15
Apr'16
Apr'17
Apr'18
Apr'19
Apr'20
Apr'21
Apr'22
Apr'23
Apr'24
$32.4B 3.6% YoY
$21.1B 3.1% YoY
65.3% margin
Cost of revenue
$11.2B 4.6% YoY
Operating income
$5,144.0M (6.2%) YoY
15.9% margin
Other: $412.0M
Net interest: $719.0M
Operating expenses
$16.1B 9.9% YoY
Pre-tax income
$4,837.0M (9.8%) YoY
14.9% margin
Net income
$3,676.0M (2.2%) YoY
11.4% margin
Income tax
$1,133.0M
23.4% tax rate
R&D
$2,735.0M 1.4% YoY
8.5% of revenue
SG&A
$10.7B 3.1% YoY
33.2% of revenue

MDT Balance Sheet Overview

Annual
Quarterly
LTM
Apr'15
Apr'16
Apr'17
Apr'18
Apr'19
Apr'20
Apr'21
Apr'22
Apr'23
Apr'24
Assets
Liabilities
Total assets
$90.0B
Current assets ($21.9B, 24.4% of total)
$8,005.0M (8.9%)
$6,128.0M (6.8%)
Other current assets
$7,802.0M (8.7%)
Non-current assets ($68.0B, 75.6% of total)
$1,616.0M (1.8%)
$13.2B (14.7%)
Other non-current assets
$46.1B (51.2%)
Financial position
$18.0B
$8,005.0M$26.0B
Cash & Short-term Investments
Total Debt

MDT Stock Ratios

MDT Earnings Surprises

Crunching data... Almost there!

MDT Dividends

MDT Dividend Yield

Crunching data... Almost there!

MDT Dividend Per Share

Competing with MDT

Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name
Market Cap
Quality rating
Intrinsic value
1Y Return
Revenue
Free Cash Flow
Revenue growth
FCF margin
Gross margin
ROIC
Total Debt to Equity
$120.9B
6.2
$114.6
21.5% undervalued
14.7%
$33.2B
$5,467.0M
2.7%
16.5%
52.7%
7.4%
53.6%
$242.4B
7.0
$174.5
24.5% undervalued
19.2%
$42.0B
$6,351.0M
4.6%
15.1%
55.6%
25.3%
31.4%
$154.5B
6.7
$34.2
67.4% overvalued
55.5%
$16.7B
$2,438.0M
17.6%
14.6%
67.0%
8.0%
50.7%
$150.5B
6.6
$305.1
22.7% overvalued
12.0%
$22.6B
$3,487.0M
10.2%
15.4%
62.8%
14.6%
28.4%
$43.4B
6.1
$54.1
24.2% overvalued
(18.0%)
$5,872.6M
$502.2M
0.9%
8.6%
77.8%
25.8%
7.4%
$34.9B
7.0
$43.1
49.8% overvalued
(29.7%)
$4,033.0M
$453.9M
11.3%
11.3%
60.4%
21.7%
120.3%
$24.7B
5.3
$65.0
146.8% undervalued
34.0%
€18.0B
€274.0M
(0.8%)
1.5%
43.1%
(4.2%)
63.4%
$21.9B
6.2
$199.6
10.4% overvalued
(3.8%)
$5,398.4M
$751.4M
(0.2%)
13.9%
44.7%
8.2%
1.9%
$21.6B
5.9
$181.2
72.0% undervalued
(15.3%)
$5,655.4M
$1,132.4M
(23.5%)
20.0%
64.3%
4.5%
43.0%
$19.4B
7.9
$134.5
50.7% overvalued
62.5%
$1,900.3M
$303.0M
12.0%
15.9%
76.4%
29.7%
6.9%
$13.6B
6.0
$190.0
8.5% undervalued
(43.2%)
$3,999.0M
$622.7M
3.5%
15.6%
70.3%
14.2%
2.3%

FAQ

What is Medtronic plc (MDT) stock rating?

As of today, Medtronic plc has a stock rating of 6 (out of 10), which is considered Good.

is Medtronic plc (MDT) a good stock to buy?

As of today, Medtronic plc has a Good stock rating, which is 21.5% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 3.2%.